SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-011700
Filing Date
2024-01-22
Accepted
2024-01-22 08:01:00
Documents
15
Period of Report
2024-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d632519d8k.htm   iXBRL 8-K 34258
2 EX-2.1 d632519dex21.htm EX-2.1 466957
3 EX-99.1 d632519dex991.htm EX-99.1 12355
7 GRAPHIC g632519g13x72.jpg GRAPHIC 6783
  Complete submission text file 0001193125-24-011700.txt   764172

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA chrs-20240119.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20240119_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20240119_pre.xml EX-101.PRE 11261
9 EXTRACTED XBRL INSTANCE DOCUMENT d632519d8k_htm.xml XML 3362
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 24547115
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)